Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
alpel.es | 1.18 | 0.1 | 4863 | 27 | 8 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
alpel.es | 0.47 | 0.6 | 1685 | 20 |
alpelisib | 0.11 | 1 | 881 | 90 |
alpelisib side effects | 1.94 | 0.8 | 6753 | 67 |
alples | 0.01 | 0.2 | 40 | 20 |
apelsa | 1.58 | 0.5 | 1124 | 2 |
alpelisib spc | 0.03 | 0.6 | 1109 | 75 |
alpelsa escuintla | 1.87 | 0.4 | 8095 | 85 |
alpelisib package insert | 1.5 | 0.6 | 7743 | 77 |
alpelisib breast cancer | 1.4 | 0.9 | 1223 | 49 |
alpelisib novartis | 1.96 | 0.9 | 3467 | 48 |
alpelisib fda label | 0.92 | 0.2 | 9197 | 88 |
alpelisib fda | 1.25 | 0.2 | 3879 | 47 |
alpelisib hyperglycemia | 0.95 | 0.4 | 547 | 69 |
alpelisib moa | 1.84 | 0.3 | 2106 | 52 |
alpelisib mechanism of action | 0.87 | 0.1 | 3005 | 94 |
alpelisib chpl | 1.97 | 0.9 | 2655 | 26 |
alpelisib piqray | 0.86 | 0.1 | 5756 | 52 |
alpelisib fda approval | 0.95 | 0.6 | 6883 | 41 |
alpelisib ema | 0.88 | 0.3 | 5467 | 13 |
alpelisib fachinfo | 0.12 | 0.7 | 4192 | 86 |
alpelisib pros | 1.26 | 0.4 | 4859 | 7 |
alpelisib nice | 1.86 | 0.2 | 8455 | 88 |
alpelisib clinical trials | 0.4 | 0.8 | 1974 | 61 |
alpelisib prescribing information | 0.36 | 0.3 | 6272 | 22 |
alpelisib scheda tecnica | 0.93 | 0.1 | 5474 | 99 |